{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:25:49Z","timestamp":1793298349896,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,3,26]],"date-time":"2014-03-26T00:00:00Z","timestamp":1395792000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s11033-014-3334-z","type":"journal-article","created":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T17:20:07Z","timestamp":1395768007000},"page":"4631-4638","source":"Crossref","is-referenced-by-count":24,"title":["No impact of SLCO1B1 521T>C, 388A>G and 411G>A polymorphisms on response to statin therapy in the Greek population"],"prefix":"10.1007","volume":"41","author":[{"given":"E.","family":"Giannakopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Ragia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Kolovou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tavridou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. D.","family":"Tselepis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Elisaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Kolovou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. G.","family":"Manolopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,26]]},"reference":[{"key":"3334_CR1","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/bmj.326.7404.1423","volume":"326","author":"MR Law","year":"2003","unstructured":"Law MR, Wald NJ, Rudnicka AR (2003) Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. Br Med J 326:1423\u20131427","journal-title":"Br Med J"},{"key":"3334_CR2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.mcna.2011.11.004","volume":"96","author":"HR Superko","year":"2012","unstructured":"Superko HR, Momary KM, Li Y (2012) Statins personalized. Med Clin North Am 96:123\u2013139","journal-title":"Med Clin North Am"},{"key":"3334_CR3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1517\/14796678.1.2.191","volume":"1","author":"I Zineh","year":"2005","unstructured":"Zineh I (2005) HMG-CoA reductase inhibitor pharmacogenomics: overview and implications for practice. Future Cardiol 1:191\u2013206","journal-title":"Future Cardiol"},{"key":"3334_CR4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.1990.03450010075034","volume":"264","author":"LR Pierce","year":"1990","unstructured":"Pierce LR, Wysowski DK, Gross TP (1990) Myopathy and rhabdomyolysis associated with lovastatin\u2013gemfibrozil combination therapy. J Am Med Assoc 264:71\u201375","journal-title":"J Am Med Assoc"},{"key":"3334_CR5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2174\/157489007782418982","volume":"2","author":"L Puccetti","year":"2007","unstructured":"Puccetti L, Acampa M, Auteri A (2007) Pharmacogenetics of statins therapy. Recent Pat Cardiovasc Drug Discov 2:228\u2013236","journal-title":"Recent Pat Cardiovasc Drug Discov"},{"key":"3334_CR6","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1517\/17425251003713519","volume":"6","author":"AC Rodrigues","year":"2010","unstructured":"Rodrigues AC (2010) Efflux and uptake transporters as determinants of statin response. Expert Opin Drug Metab Toxicol 6:621\u2013632","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"3334_CR7","doi-asserted-by":"crossref","first-page":"35669","DOI":"10.1074\/jbc.M103792200","volume":"276","author":"RG Tirona","year":"2001","unstructured":"Tirona RG, Leake BF, Merino G, Kim RB (2001) Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans. J Biol Chem 276:35669\u201335675","journal-title":"J Biol Chem"},{"key":"3334_CR8","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1124\/jpet.302.2.804","volume":"302","author":"T Nozawa","year":"2002","unstructured":"Nozawa T, Nakajima M, Tamai I, Noda K, Nezu J, Sai Y, Tsuji A, Yokoi T (2002) Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis. J Pharmacol Exp Ther 302:804\u2013813","journal-title":"J Pharmacol Exp Ther"},{"key":"3334_CR9","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0009-9236(03)00060-2","volume":"73","author":"Y Nishizato","year":"2003","unstructured":"Nishizato Y, Ieiri I, Suzuki H, Kimura M, Kawabata K, Hirota T, Takane H, Irie S, Kusuhara H, Urasaki Y, Urae A, Higuchi S, Otsubo K, Sugiyama Y (2003) Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics. Clin Pharmacol Ther 73:554\u2013565","journal-title":"Clin Pharmacol Ther"},{"key":"3334_CR10","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/01.fpc.0000114750.08559.32","volume":"14","author":"M Niemi","year":"2004","unstructured":"Niemi M, Schaeffeler E, Lang T, Fromm MF, Neuvonen M, Kyrklund C, Backman JT, Kerb R, Schwab M, Neuvonen PJ, Eichelbaum M, Kivisto KT (2004) High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1). Pharmacogenetics 14:429\u2013440","journal-title":"Pharmacogenetics"},{"key":"3334_CR11","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/01.fpc.0000170913.73780.5f","volume":"15","author":"Y Kameyama","year":"2005","unstructured":"Kameyama Y, Yamashita K, Kobayashi K, Hosokawa M, Chiba K (2005) Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells. Pharmacogenet Genomics 15:513\u2013522","journal-title":"Pharmacogenet Genomics"},{"key":"3334_CR12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1124\/jpet.102.043026","volume":"304","author":"RG Tirona","year":"2003","unstructured":"Tirona RG, Leake BF, Wolkoff AW, Kim RB (2003) Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation. J Pharmacol Exp Ther 304:223\u2013228","journal-title":"J Pharmacol Exp Ther"},{"key":"3334_CR13","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1124\/dmd.104.001909","volume":"33","author":"T Nozawa","year":"2005","unstructured":"Nozawa T, Minami H, Sugiura S, Tsuji A, Tamai I (2005) Role of organic anion transporter OATP1B1 (OATP-C) in hepatic uptake of irinotecan and its active metabolite, 7-ethyl-10-hydroxycamptothecin: in vitro evidence and effect of single nucleotide polymorphisms. Drug Metab Dispos 33:434\u2013439","journal-title":"Drug Metab Dispos"},{"key":"3334_CR14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00228-006-0123-1","volume":"62","author":"MK Pasanen","year":"2006","unstructured":"Pasanen MK, Backman JT, Neuvonen PJ, Niemi M (2006) Frequencies of single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide 1B1 SLCO1B1 gene in a Finnish population. Eur J Clin Pharmacol 62:409\u2013415","journal-title":"Eur J Clin Pharmacol"},{"key":"3334_CR15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00228-007-0409-y","volume":"64","author":"J Mwinyi","year":"2008","unstructured":"Mwinyi J, Kopke K, Schaefer M, Roots I, Gerloff T (2008) Comparison of SLCO1B1 sequence variability among German, Turkish, and African populations. Eur J Clin Pharmacol 64:257\u2013266","journal-title":"Eur J Clin Pharmacol"},{"key":"3334_CR16","doi-asserted-by":"crossref","first-page":"e13574","DOI":"10.1371\/journal.pone.0013574","volume":"5","author":"R Chen","year":"2010","unstructured":"Chen R, Davydov EV, Sirota M, Butte AJ (2010) Non-synonymous and synonymous coding SNPs show similar likelihood and effect size of human disease association. PLoS One 5:e13574","journal-title":"PLoS One"},{"key":"3334_CR17","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/gbe\/evr076","volume":"3","author":"YY Waldman","year":"2011","unstructured":"Waldman YY, Tuller T, Keinan A, Ruppin E (2011) Selection for translation efficiency on synonymous polymorphisms in recent human evolution. Genome Biol Evol 3:749\u2013761","journal-title":"Genome Biol Evol"},{"key":"3334_CR18","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMoa0801936","volume":"359","author":"E Link","year":"2008","unstructured":"Link E, Parish S, Armitage J, Bowman L, Heath S, Matsuda F, Gut I, Lathrop M, Collins R (2008) SLCO1B1 variants and statin-induced myopathy\u2014a genomewide study. N Engl J Med 359:789\u2013799","journal-title":"N Engl J Med"},{"key":"3334_CR19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/clpt.2012.57","volume":"92","author":"RA Wilke","year":"2012","unstructured":"Wilke RA, Ramsey LB, Johnson SG, Maxwell WD, McLeod HL, Voora D, Krauss RM, Roden DM, Feng Q, Cooper-Dehoff RM, Gong L, Klein TE, Wadelius M, Niemi M (2012) The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy. Clin Pharmacol Ther 92:112\u2013117","journal-title":"Clin Pharmacol Ther"},{"key":"3334_CR20","first-page":"91","volume-title":"Genetic data analysis II","author":"B Weir","year":"1996","unstructured":"Weir B (1996) Disequilibrium. In: Sunderland M (ed) Genetic data analysis II. Sinaur Associates, Sunderland, pp 91\u2013139"},{"key":"3334_CR21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","volume":"21","author":"JC Barrett","year":"2005","unstructured":"Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263\u2013265","journal-title":"Bioinformatics"},{"key":"3334_CR22","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1086\/521987","volume":"81","author":"SR Browning","year":"2007","unstructured":"Browning SR, Browning BL (2007) Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. Am J Hum Genet 81:1084\u20131097","journal-title":"Am J Hum Genet"},{"key":"3334_CR23","unstructured":"NCBI dbSNP Build 137. http:\/\/www.ncbinlmnihgov\/projects\/SNP\/snp_refcgi?rs=rs1057868"},{"key":"3334_CR24","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2217\/14622416.9.9.1217","volume":"9","author":"P Couvert","year":"2008","unstructured":"Couvert P, Giral P, Dejager S, Gu J, Huby T, Chapman MJ, Bruckert E, Carrie A (2008) Association between a frequent allele of the gene encoding OATP1B1 and enhanced LDL-lowering response to fluvastatin therapy. Pharmacogenomics 9:1217\u20131227","journal-title":"Pharmacogenomics"},{"key":"3334_CR25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.clpt.2003.12.016","volume":"75","author":"J Mwinyi","year":"2004","unstructured":"Mwinyi J, Johne A, Bauer S, Roots I, Gerloff T (2004) Evidence for inverse effects of OATP-C (SLC21A6) 5 and 1b haplotypes on pravastatin kinetics. Clin Pharmacol Ther 75:415\u2013421","journal-title":"Clin Pharmacol Ther"},{"key":"3334_CR26","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/eurheartj\/ehs344","volume":"34","author":"JC Hopewell","year":"2012","unstructured":"Hopewell JC, Parish S, Offer A, Link E, Clarke R, Lathrop M, Armitage J, Collins R (2012) Impact of common genetic variation on response to simvastatin therapy among 18,705 participants in the Heart Protection Study. Eur Heart J 34:982\u2013992","journal-title":"Eur Heart J"},{"key":"3334_CR27","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/CIRCGENETICS.109.898502","volume":"3","author":"KM Bailey","year":"2010","unstructured":"Bailey KM, Romaine SP, Jackson BM, Farrin AJ, Efthymiou M, Barth JH, Copeland J, McCormack T, Whitehead A, Flather MD, Samani NJ, Nixon J, Hall AS, Balmforth AJ (2010) Hepatic metabolism and transporter gene variants enhance response to rosuvastatin in patients with acute myocardial infarction: the GEOSTAT-1 study. Circ Cardiovasc Genet 3:276\u2013285","journal-title":"Circ Cardiovasc Genet"},{"key":"3334_CR28","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/sj.tpj.6500328","volume":"5","author":"JF Thompson","year":"2005","unstructured":"Thompson JF, Man M, Johnson KJ, Wood LS, Lira ME, Lloyd DB, Banerjee P, Milos PM, Myrand SP, Paulauskis J, Milad MA, Sasiela WJ (2005) An association study of 43 SNPs in 16 candidate genes with atorvastatin response. Pharmacogenomics J 5:352\u2013358","journal-title":"Pharmacogenomics J"},{"key":"3334_CR29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.clpt.2006.01.010","volume":"79","author":"M Igel","year":"2006","unstructured":"Igel M, Arnold KA, Niemi M, Hofmann U, Schwab M, Lutjohann D, von Bergmann K, Eichelbaum M, Kivisto KT (2006) Impact of the SLCO1B1 polymorphism on the pharmacokinetics and lipid-lowering efficacy of multiple-dose pravastatin. Clin Pharmacol Ther 79:419\u2013426","journal-title":"Clin Pharmacol Ther"},{"key":"3334_CR30","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.atherosclerosis.2011.09.028","volume":"220","author":"H Akao","year":"2012","unstructured":"Akao H, Polisecki E, Kajinami K, Trompet S, Robertson M, Ford I, Jukema JW, de Craen AJ, Westendorp RG, Shepherd J, Packard C, Buckley BM, Schaefer EJ (2012) Genetic variation at the SLCO1B1 gene locus and low density lipoprotein cholesterol lowering response to pravastatin in the elderly. Atherosclerosis 220:413\u2013417","journal-title":"Atherosclerosis"},{"key":"3334_CR31","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1515\/cclm.2011.804","volume":"50","author":"VA Sortica","year":"2012","unstructured":"Sortica VA, Fiegenbaum M, Lima LO, Van der Sand CR, Van der Sand LC, Ferreira ME, Pires RC, Hutz MH (2012) SLCO1B1 gene variability influences lipid-lowering efficacy on simvastatin therapy in southern Brazilians. Clin Chem Lab Med 50:441\u2013448","journal-title":"Clin Chem Lab Med"},{"key":"3334_CR32","first-page":"8","volume":"417C","author":"AC Rodrigues","year":"2012","unstructured":"Rodrigues AC, Sobrino B, Genvigir FD, Willrich MA, Arazi SS, Dorea EL, Bernik MM, Bertolami M, Faludi AA, Brion MJ, Carracedo A, Hirata MH, Hirata RD (2012) Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response. Clin Chim Acta 417C:8\u201311","journal-title":"Clin Chim Acta"},{"key":"3334_CR33","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s10038-006-0025-1","volume":"51","author":"H Takane","year":"2006","unstructured":"Takane H, Miyata M, Burioka N, Shigemasa C, Shimizu E, Otsubo K, Ieiri I (2006) Pharmacogenetic determinants of variability in lipid-lowering response to pravastatin therapy. J Human Genet 51:822\u2013826","journal-title":"J Human Genet"},{"key":"3334_CR34","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2133\/dmpk.19.375","volume":"19","author":"R Tachibana-Iimori","year":"2004","unstructured":"Tachibana-Iimori R, Tabara Y, Kusuhara H, Kohara K, Kawamoto R, Nakura J, Tokunaga K, Kondo I, Sugiyama Y, Miki T (2004) Effect of genetic polymorphism of OATP-C (SLCO1B1) on lipid-lowering response to HMG-CoA reductase inhibitors. Drug Metab Pharmacokinet 19:375\u2013380","journal-title":"Drug Metab Pharmacokinet"},{"key":"3334_CR35","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2125.2007.02892.x","volume":"64","author":"W Zhang","year":"2007","unstructured":"Zhang W, Chen BL, Ozdemir V, He YJ, Zhou G, Peng DD, Deng S, Xie QY, Xie W, Xu LY, Wang LC, Fan L, Wang A, Zhou HH (2007) SLCO1B1 521T\u2192C functional genetic polymorphism and lipid-lowering efficacy of multiple-dose pravastatin in Chinese coronary heart disease patients. Br J Clin Pharmacol 64:346\u2013352","journal-title":"Br J Clin Pharmacol"},{"key":"3334_CR36","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/FPC.0b013e3283557c98","volume":"22","author":"M Hu","year":"2012","unstructured":"Hu M, Mak VW, Tomlinson B (2012) Intronic variants in SLCO1B1 related to statin-induced myopathy are associated with the low-density lipoprotein cholesterol response to statins in Chinese patients with hyperlipidaemia. Pharmacogenet Genomics 22:803\u2013806","journal-title":"Pharmacogenet Genomics"},{"key":"3334_CR37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/pr.110.002857","volume":"63","author":"M Niemi","year":"2011","unstructured":"Niemi M, Pasanen MK, Neuvonen PJ (2011) Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake. Pharmacol Rev 63:157\u2013181","journal-title":"Pharmacol Rev"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-014-3334-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-014-3334-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-014-3334-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T03:16:38Z","timestamp":1559358998000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-014-3334-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,26]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["3334"],"URL":"https:\/\/doi.org\/10.1007\/s11033-014-3334-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,26]]}}}